Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Clinical trial NCT03214354 · RECRUITING

Trial details

NCT number: NCT03214354
Sponsor: University of Calgary
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Stem Cell Transplant Complications Red Blood Cell Disorder Pure Red Cell Aplasia

Start date: 2017-07-05
Primary completion: 2028-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.